Orchid Research Labs awarded Partner of Choice Award by F&S

Published on Mon, Apr 30, 2007 at 14:50 |  Source : Moneycontrol.com

Updated at Mon, Apr 30, 2007 at 16:38  

19004 Investors following Orchid Chemical. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

The Chennai-based global pharma major, Orchid Chemicals & Pharmaceuticals Ltd . (Orchid) today announced that its wholly-owned Drug Discovery subsidiary in Chennai, Orchid Research Laboratories Ltd (ORLL) has been conferred the Frost & Sullivan Award for Partner of Choice in Contract Research - Collaborative Drug Discovery.

 

The "Partner of Choice Awards 2007" organized by Frost & Sullivan , recognize the best Indian Research and Manufacturing Services Capability in the Life Sciences arena and assess their Global Competitiveness. The companies that have been conferred the award are those who have achieved and sustained excellence in their industry value chain component with the diligence, perseverance, foresight and dedication required to develop a successful organization and sustain continuous learning to be the true Partners of Choice. The award was judged based on 4 broad parameters viz., Knowledge capabilities, Infrastructure Capabilities, Competitive Fitness and Business Dynamics.

 

Commenting on this honour, Dr CB Rao, Dy. Managing Director, Orchid Chemicals & Pharmaceuticals Ltd said, "We are happy that our drug discovery entity, Orchid Research Laboratories has been selected by Frost & Sullivan for the Partner of Choice award. This is a further reiteration of the state-of-the-art infrastructure, processes and competencies that we possess, making us a true partner of choice."  

 

Sourced From: Orchid Chemicals & Pharmaceuticals Ltd

 

  

Trending News

Business News

Sony to roll-out ICS update next week, Xperia PLAY gets the boot
Reebok execs named in Rs 870 cr fraud denied anticipatory bail "Reebok execs named in Rs 870 cr fraud denied anticipatory bail"

Live Updates: KKR favourites in last-over battle

Rel Comm Q4 Cons Net Revenue Up 5% At `5,310 Cr (QoQ)

The latest earning numbers FIRST on CNBC-TV18
Videos

May 25 2012, 22:26

NHPC posts profit amid capacity addition, delay woes

- in Results Boardroom

Interviews

May 27 2012, 11:52 | Source: CNBC-TV18

Expect to maintain EBIDTA margin ahead: Wockhardt  

May 27 2012, 11:00 | Source: CNBC-TV18

e-commerce market in India: What's in store?  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!